YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
aitiologic GmbH Financing co-led by Heal Capital and Ananda Impact Ventures will advance the Aitios® platform and ongoing validation of lead program to identify preeclampsia risk in a pregnancy's first trimester Dr. Gordon Sanghera CBE FRS…
Company Logo The global transcriptome sequencing market is projected to reach $11.8 billion by 2035, growing at a 7.3% CAGR from 2025 to 2035. Growth is driven by falling sequencing costs, precision medicine, drug discovery, biomarker deve…
Empire Metals Ltd (AIM:EEE, OTCQX:EPMLF) has upgraded its Pitfield project in Western Australia to 8.16 billion tonnes, confirming it as the world's largest titanium resource. That includes a first Measured Resource of 374 million tonnes a…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Next Generation Sequencing Services Market size & share revenue was valued at approxim…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Targeted DNA RNA Sequencing Market size & share revenue was valued at approximately US…
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Agilent Technologies (NYSE:A) highlighted new technologies and scientific data aimed at advancing cancer research. The compa…
Earlier this week, Cepheid, a Danaher company, and Oxford Nanopore Technologies expanded their partnership to develop faster, more comprehensive molecular workflows for identifying bacterial and fungal pathogens, antimicrobial resistance,…
Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research SUNNYVALE, Calif. and OXFORD, England, April 15, 2026 /PRNewswire/ -- Cepheid, a Danaher company and a leader in molecular diagn…
Company Logo Optical Genome Mapping MarketOptical Genome Mapping Market·GlobeNewswire Inc. Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Optical Genome Mapping Market Report 2026" has been added to ResearchAndMarkets.com's offering. The…
Insiders were net buyers of Oxford Nanopore Technologies plc's (LON:ONT ) stock during the past year. That is, insiders bought more stock than they sold. While insider transactions are not the most important thing when it comes to long-ter…
Company Logo Government-backed population genomics projects escalate demand, while AI and long-read sequencing tech enhance data analysis speed and accuracy Whole Genome Sequencing MarketWhole Genome Sequencing Market·GlobeNewswire Inc. Du…
Oxford Nanopore Technologies logo Key Points 24% constant currency revenue growth: Oxford Nanopore beat its 20%-23% guidance, driven by strong demand across end markets—clinical >60%, biopharma +30%, applied industrial +27% and research +1…
Company Logo Canadian Next-Generation Sequencing (NGS) MarketCanadian Next-Generation Sequencing (NGS) Market Dublin, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The "Canada Next-Generation Sequencing (NGS) Market - A Canada and Regional Analysis: F…
Oxford Nanopore Technologies logo Key Points Oxford Nanopore estimated 2025 revenue of GBP 223–224 million, or 24% constant-currency growth, with just over GBP 300 million in cash, ~70% of revenue from consumables and a 28% five-year CAGR;…
Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic ("IVD") device in the UK and Europe: the GridION™ Dx. OXFORD, England, January 12, 2026--(BUSINESS WIRE)--Oxford Nanopore Techn…
Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a…
Bio-Techne (TECH) made headlines by announcing an expanded partnership with Oxford Nanopore Technologies. This move extends their collaboration through 2032 and empowers Bio-Techne to broaden its portfolio of genetic testing products. See…
Grants Bio-Techne expanded commercial rights to develop a portfolio of genetics products beyond the recently launched AmplideX® Nanopore Carrier Plus Kit Establishes a framework to define and propose future portfolios Extends collaboration…
BOSTON, Sept. 10, 2025 /PRNewswire/ -- Volta Labs today announced that the Prinses Máxima Center for Pediatric Oncology has acquired the Callisto™ platform to streamline sample preparation across multiple genomics workflows, supporting bot…
Oxford Nanopore Technologies (LON:ONT) First Half 2025 Results Key Financial Results Revenue: UK£105.6m (up 26% from 1H 2024). Net loss: UK£71.8m (loss narrowed by 3.9% from 1H 2024). UK£0.075 loss per share (improved from UK£0.087 loss in…
It's been a mediocre week for Oxford Nanopore Technologies plc (LON:ONT) shareholders, with the stock dropping 16% to UK£1.64 in the week since its latest half-yearly results. The business exceeded expectations with revenue of UK£106m comi…
Nestlé (NESN.SW) Consumer giant Nestlé (NESN.SW) saw its shares lose ground on Tuesday morning after the company moved to dismiss CEO Laurent Friexe for not disclosing a romantic relationship with a subordinate. The maker of Nescafe drinks…
New adventitious viral agent (AVA) detection test offers rapid, sensitive, and affordable viral screening for biomanufacturers OXFORD, England & VIENNA, Austria, August 07, 2025--(BUSINESS WIRE)--ViruSure, a global leader in pathogen safet…
We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd…
European stocks ended mixed on Monday, as investors anxiously await developments on tariff talks, with an August 1 deadline nearing. The FTSE 100 (^FTSE) index closed up 20.87 points, 0.2%, at 9,012.99, ending a day above the 9,000 points…
Oxford Nanopore Technologies (LON:ONT) Full Year 2024 Results Key Financial Results Revenue: UK£183.2m (up 8.0% from FY 2023). Net loss: UK£146.2m (loss narrowed by 5.4% from FY 2023). UK£0.16 loss per share (improved from UK£0.18 loss in…
Aligos Therapeutics SOUTH SAN FRANCISCO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, the “Company”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to ad…
Key Insights Given the large stake in the stock by institutions, Oxford Nanopore Technologies' stock price might be vulnerable to their trading decisions The top 11 shareholders own 50% of the company Insiders have been selling lately To g…